ACH
EXAS

ArrowMark Colorado Holdings’s Exact Sciences EXAS Stock Holding History

ArrowMark Colorado Holdings’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-88,285
Closed -$8.97M – 304
2025
Q4 		$8.97M Sell
88,285
-509,646
-85% -$40.9M 0.2% 144
2025
Q3 		$32.7M Buy
597,931
+113,603
+23% +$5.68M 0.61% 53
2025
Q2 		$25.7M Sell
484,328
-105,873
-18% -$5.38M 0.46% 69
2025
Q1 		$25.5M Buy
590,201
+150,714
+34% +$7.63M 0.41% 75
2024
Q4 		$24.7M Buy
439,487
+19,528
+5% +$1.22M 0.33% 84
2024
Q3 		$28.6M Buy
+419,959
New +$23.7M 0.37% 77
2022
Q2 		– Sell
-397,268
Closed -$27.8M – 334
2022
Q1 		$27.8M Sell
397,268
-1,441
-0.4% -$105K 0.24% 104
2021
Q4 		$31M Sell
398,709
-471
-0.1% -$41.6K 0.25% 101
2021
Q3 		$38.1M Buy
399,180
+91,910
+30% +$9.7M 0.3% 92
2021
Q2 		$38.2M Sell
307,270
-1,890
-0.6% -$226K 0.29% 94
2021
Q1 		$40.7M Sell
309,160
-194,673
-39% -$26.6M 0.3% 86
2020
Q4 		$66.8M Sell
503,833
-3,248
-0.6% -$393K 0.52% 59
2020
Q3 		$51.7M Sell
507,081
-108,514
-18% -$9.37M 0.49% 62
2020
Q2 		$53.5M Buy
615,595
+45,303
+8% +$3.62M 0.55% 60
2020
Q1 		$33.1M Buy
570,292
+566,667
+15,632% +$46M 0.43% 70
2019
Q4 		$335K Buy
3,625
+8
+0.2% +$703 ﹤0.01% 297
2019
Q3 		$327K Sell
3,617
-604,987
-99% -$68.9M ﹤0.01% 302
2019
Q2 		$71.8M Buy
608,604
+6,246
+1% +$629K 0.69% 53
2019
Q1 		$52.2M Sell
602,358
-35,549
-6% -$3.03M 0.49% 68
2018
Q4 		$40.3M Buy
637,907
+13,671
+2% +$938K 0.42% 77
2018
Q3 		$49.3M Sell
624,236
-187,009
-23% -$12.2M 0.41% 84
2018
Q2 		$48.5M Sell
811,245
-293,468
-27% -$15.8M 0.45% 83
2018
Q1 		$44.6M Sell
1,104,713
-4,961
-0.4% -$242K 0.45% 83
2017
Q4 		$58.3M Sell
1,109,674
-848,916
-43% -$45.3M 0.59% 60
2017
Q3 		$92.3M Sell
1,958,590
-380,918
-16% -$15.3M 1.05% 28
2017
Q2 		$82.7M Sell
2,339,508
-459,075
-16% -$14.2M 1.02% 31
2017
Q1 		$66.1M Sell
2,798,583
-298,351
-10% -$5.91M 0.9% 38
2016
Q4 		$41.4M Buy
3,096,934
+1,141,786
+58% +$18.4M 0.65% 51
2016
Q3 		$36.3M Sell
1,955,148
-101,343
-5% -$1.79M 0.66% 56
2016
Q2 		$25.2M Buy
2,056,491
+1,826,106
+793% +$13.8M 0.51% 68
2016
Q1 		$1.55M Sell
230,385
-19,485
-8% -$125K 0.03% 202
2015
Q4 		$2.31M Sell
249,870
-512,165
-67% -$4.76M 0.06% 179
2015
Q3 		$13.7M Buy
762,035
+102,886
+16% +$2.36M 0.37% 88
2015
Q2 		$19.6M Sell
659,149
-400,798
-38% -$10.1M 0.48% 64
2015
Q1 		$23.3M Buy
1,059,947
+289,803
+38% +$7.35M 0.6% 59
2014
Q4 		$21.1M Buy
770,144
+47,265
+7% +$1.15M 0.54% 62
2014
Q3 		$14M Sell
722,879
-520,208
-42% -$9.54M 0.38% 87
2014
Q2 		$21.2M Buy
1,243,087
+28,388
+2% +$391K 0.6% 61
2014
Q1 		$17.2M Buy
1,214,699
+66,562
+6% +$899K 0.56% 67
2013
Q4 		$13.5M Buy
1,148,137
+292,417
+34% +$3.35M 0.42% 90
2013
Q3 		$10.1M Buy
+855,720
New +$11M 0.33% 114

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

ArrowMark Colorado Holdings's EXAS Position: Q1 2026 in Review

ArrowMark Colorado Holdings sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 88,285 shares — an estimated $8.97M sold.

ArrowMark Colorado Holdings first reported a position in EXAS in Q3 2013 and held it in 41 quarters. The position peaked at $92.3M in Q3 2017. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • ArrowMark Colorado Holdings reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 88,285 Exact Sciences shares in Q1 2026, an estimated $8.97M.
  • ArrowMark Colorado Holdings first reported a position in Exact Sciences in Q3 2013 and held it in 41 quarters.
  • ArrowMark Colorado Holdings's Exact Sciences position peaked at $92.3M in Q3 2017.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2026, filed 15 May 2026.